Over 100 HealthTech projects delivered.
A selection of recent engagements across new HealthTech business models, scouting & due diligence, and trainings & workshops.
HealthTech offering development and internationalization for a public actor
Challenge
A large public healthcare actor with existing assets in patient data and home care services wanted to develop a new HealthTech offering for pharma and MedTech clients, and expand it internationally.
Approach
Conducted market sizing across 5 European markets, identified unmet needs among pharma and MedTech buyers, and designed a service portfolio leveraging the client's proprietary data and care infrastructure. Developed the go-to-market strategy with pricing models, partnership frameworks, and a phased internationalization roadmap.
Outcome
Launched the offering in 2 new markets within 6 months. Secured pilot agreements with 3 pharma companies and built a repeatable sales playbook for further expansion.
HealthTech scouting to improve diagnosis rates for a pharma company
Challenge
A leading pharma company needed to identify HealthTech solutions that could improve diagnosis rates for an underdiagnosed rare disease, where fewer than 30% of patients receive a timely diagnosis.
Approach
Mapped the full patient pathway from symptom onset to confirmed diagnosis across 3 countries. Screened 80+ HealthTech companies across AI-assisted screening, remote monitoring, and patient engagement platforms. Shortlisted 12 candidates and assessed each on clinical evidence, scalability, and integration potential.
Outcome
Delivered a prioritized shortlist of 5 HealthTech partners with detailed profiles and integration roadmaps. Two partnerships were initiated within 3 months of project completion.
Due diligence of an innovative primary care chain for a VC
Challenge
A VC fund evaluating a significant investment in a German primary care chain needed an independent assessment of the company's business model, regulatory positioning, and operational readiness for scaling.
Approach
Conducted in-depth analysis across 6 dimensions: business model sustainability, competitive landscape, regulatory status (KV licensing, MVZ regulations), technology stack maturity, unit economics per clinic, and management team capability. Interviewed 8 stakeholders including the founder, clinic directors, and industry experts from the HGM network.
Outcome
Delivered a 40-page due diligence report with a clear investment recommendation. Identified 3 key risks and proposed mitigation strategies that were incorporated into the term sheet.
Digital health landscape report for a leading lab chain
Challenge
A major lab chain wanted to understand how digital health platforms and direct-to-consumer models were reshaping the diagnostics value chain, and identify where to position for growth.
Approach
Analyzed 60+ digital health platforms across telemedicine, at-home testing, AI-driven diagnostics, and patient engagement. Segmented opportunities by threat level and partnership potential. Created a proprietary landscape map with competitive positioning for each segment.
Outcome
Identified 4 high-priority opportunity areas and recommended specific partnership and build-vs-buy strategies. The report became a core input for the client's 3-year digital strategy.
AI-driven clinical decision support strategy for a pharma company
Challenge
A leading pharma company sought to develop an AI-driven clinical decision support (AI-CDS) tool in partnership with university hospitals, but lacked a clear strategic framework and understanding of the competitive landscape.
Approach
Served as ongoing strategic sparring partner over 6 months. Mapped the AI-CDS competitive landscape (OpenEvidence, AMBOSS, Glass Health, and 15+ others). Facilitated workshops with clinical and commercial stakeholders at 3 university hospitals. Developed the product positioning, go-to-market strategy, and regulatory pathway (EU AI Act, MDR implications).
Outcome
Defined the product roadmap and partnership model. The AI-CDS tool entered clinical validation at 2 university hospitals with a clear path to CE marking.
Moonshot innovation sparring for a leading MedTech
Challenge
The Chief Innovation Officer of a leading MedTech company needed external sparring to develop strategic narratives, build financial business cases, and design an innovation vehicle for breakthrough HealthTech initiatives.
Approach
Provided bi-weekly strategic sparring sessions over 4 months. Co-developed business cases for 3 moonshot initiatives spanning AI-powered diagnostics, connected care platforms, and new-market entry strategies. Built financial models with scenario analysis and created board-ready presentation materials.
Outcome
2 of 3 moonshot initiatives received board approval and dedicated funding. The innovation vehicle framework is now used as a template for future breakthrough projects across the organization.
HealthTech training for the innovation team of a global health insurer
Challenge
The innovation team of a global health insurer needed to rapidly build HealthTech literacy to evaluate partnership opportunities and guide internal digital health initiatives.
Approach
Designed and delivered a gamified one-day training program covering the HealthTech landscape, key business models, AI in healthcare, and evaluation frameworks for digital health solutions. Included hands-on exercises where teams assessed real HealthTech companies using a structured scoring methodology.
Outcome
30+ team members trained in a single day. Post-training survey showed a 4.7/5 satisfaction score. The evaluation framework is now used as the standard tool for the team's ongoing HealthTech assessments.
Expansion strategy for a leading care operations scale-up from Norway
Challenge
A leading provider of care operations solutions for hospitals in Norway, backed by a private equity fund, specializes in optimizing patient flows at the department, hospital, and regional levels. The company was looking to expand beyond Norway into EU-5 markets (UK, Germany, Spain, Italy, and France), and needed to assess and compare these markets to inform the go-to-market strategy.
Approach
The approach consisted of three key elements. First, conducting 5+ interviews with senior experts in each target market to understand local needs. Second, holding a workshop with the scale-up's management board and the private equity firm to shape the strategic direction. Third, developing a go-to-market framework that segments market needs to tailor the scale-up's value proposition and positioning.
Outcome
Secured buy-in from key decision-makers at both the scale-up and the private equity firm. Implemented the go-to-market framework within commercial teams, capturing client need archetypes and aligning them with tailored value propositions. Mapped the most relevant M&A targets to support accelerated inorganic growth. Facilitated introductions to key stakeholders in each market to initiate customer and partnership discussions.